Autoimmune epilepsy outcomes depend heavily on antibody type

December 04, 2015

PHILADELPHIA, December 4, 2015 - Immune dysfunction is increasingly recognized as a cause of drug-resistant epilepsy but how or why the immune system attacks nerve cells - and the consequences on seizure control - are not well understood. Two studies presented at the American Epilepsy Society's (AES) 69th Annual Meeting explore how different types of autoimmune response elicit markedly different responses in patients with drug-resistant epilepsy.

A study by researchers from the University of Toronto and Western University (abstract 3.153) offers evidence that not all autoimmune epilepsies are equal, at least in terms of prognosis and response to treatment.

Previous studies have shown that antibodies against intracellular proteins are associated with a worse prognosis and poorer response to immunotherapy than antibodies against cell surface proteins. To explore other differences that might exist in these two groups, the authors examined clinical and EEG data from nine patients with autoimmune epilepsy. Three of the patients had antibodies targeting the intracellular Ma2 protein, while six patients had antibodies against the cell surface LGI1 protein.

Their analysis reveals that all of the anti-Ma2 patients had visited the intensive care unit at some point during their illness and all had experienced status epilepticus -- when seizures last too long or occur too closely together --while the same was true for only one patient with LGI1. While epilepsy was the primary concern of patients with LGI1, those with anti-Ma2 tended to experience additional neurological issues such as narcolepsy or behavioral changes. Cancerous tumors were detected in two of the three anti-Ma2 patients but none of the LGI1 patients. Both groups had poorly controlled epilepsy despite taking multi-drug regimens, and anti-Ma2 patients responded less to immunotherapy than did LGI1 patients.

"Overall, patients with anti-Ma2 antibodies exhibited a more malignant course compared to patients with LGI1 antibodies. Seizures were uncontrolled by anticonvulsant drugs in the majority of LGI1 patients and all anti-Ma2 patients, but responded to immunotherapy in a greater proportion of LGI1 patients than anti-Ma2 patients" says author Claude Steriade, MDCM, a neurology resident at the University of Toronto.

A second study (abstract 2.320) suggests that some patients with autoimmune epilepsy may benefit from brain surgery, and that antibody type does not appear to influence surgery outcomes.

A team led by researchers from Hospital Clinic in Barcelona, Spain, conducted a retrospective, multi-center study to assess the outcomes of 11 patients with drug-resistant epilepsy and immune dysfunction who underwent brain surgery. Before surgery, a variety of autoimmune antibodies were identified in each of the patients (including two patients with antiMa2 antibodies, 5 with antiGAD, 1 with antiHu, 2 with antiVGKC, 1 with antiLG1 and 1 with antiCASPR2).

Five patients were seizure-free or almost seizure-free at the last post-surgical follow-up visit, and those patients had a diverse array of antineuronal antibodies including LG1 1, VGKC associated to anti GAD 1, anti Hu 1, anti Ma2 1 and anti GAD 1.

"Surgical treatment may improve seizure frequency in some patients with drug-resistant epilepsy associated with antineuronal antibodies. But the small number of cases and the different approaches strongly suggest the need for guidelines to better classify these patients and international registries to study outcomes in larger populations," says author Mar Carreño, M.D., Ph.D., a professor and epileptologist at Hospital Clinic, Barcelona.
About the American Epilepsy Society:

The American Epilepsy Society is a medical and scientific society whose members are engaged in research and clinical care for people with epilepsy. For more than 75 years, AES has provided a dynamic global forum where professionals from academia, private practice, not-for-profit, government and industry can learn, share and grow. Find out more at

Information Contacts:

Natalie Judd, Big Voice Communication, 203-389-5223,
Tess Aaronson, Big Voice Communication, 203-389-5223,

American Epilepsy Society

Related Epilepsy Articles from Brightsurf:

Focal epilepsy often overlooked
Having subtler symptoms, a form of epilepsy that affects only one part of the brain often goes undiagnosed long enough to cause unexpected seizures that contribute to car crashes, a new study finds.

Antibodies in the brain trigger epilepsy
Certain forms of epilepsy are accompanied by inflammation of important brain regions.

Breaching the brain's defense causes epilepsy
Epileptic seizures can happen to anyone. But how do they occur and what initiates such a rapid response?

Using connectomics to understand epilepsy
Abnormalities in structural brain networks and how brain regions communicate may underlie a variety of disorders, including epilepsy, which is one focus of a two-part Special Issue on the Brain Connectome in Brain Connectivity, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.

Epilepsy: Triangular relationship in the brain
When an epileptic seizure occurs in the brain, the nerve cells lose their usual pattern and fire in a very fast rhythm.

How concussions may lead to epilepsy
Researchers have identified a cellular response to repeated concussions that may contribute to seizures in mice like those observed following traumatic brain injury in humans.

Understanding epilepsy in pediatric tumors
A KAIST research team led by Professor Jeong Ho Lee of the Graduate School of Medical Science and Engineering has recently identified a neuronal BRAF somatic mutation that causes intrinsic epileptogenicity in pediatric brain tumors.

Can medical marijuana help treat intractable epilepsy?
A new British Journal of Clinical Pharmacology review examines the potential of medicinal cannabis -- or medical marijuana -- for helping patients with intractable epilepsy, in which seizures fail to come under control with standard anticonvulsant treatment.

Fertility rates no different for women with epilepsy
'Myth-busting' study among women with no history of infertility finds that those with epilepsy are just as likely to become pregnant as those without.

Do women with epilepsy have similar likelihood of pregnancy?
Women with epilepsy without a history of infertility or related disorders who wanted to become pregnant were about as likely as their peers without epilepsy to become pregnant.

Read More: Epilepsy News and Epilepsy Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to